AzTrials
AzTrials

BilingualismNEUROSWITCHNCT02391493

Neural Correlates of Language Control in Bilinguals. Functional MRI and Stimulation Mapping Data in Awake Surgery.

A study testing functional magnetic resonance imaging in people with Bilingualism, run by University Hospital, Toulouse at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

For bilingual and multilingual patients, brain activation and Electric Stimulation Mapping studies have shown that different languages may be localized, at least partially, in distinct microanatomical systems located within the same gross anatomical areas. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Bilingualism
What is being tested?
functional magnetic resonance imaging
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteFrance
Study dates
Nov 2014to Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients:
  • Bilingual patients with a pathology indicating an intervention in awake surgery (e.g. low-grade glioma)
  • At least C1-level of the CECR in both languages
  • At least 12 years of schooling (French BAC)
  • Right-handed (Edinburgh test, 1971)
  • Performance indicator Eastern Cooperative Oncology Group 0-2 (cf. annexe)
Show all 15Show fewer
  • Life expectation > 6 month
  • Affiliated to social insurance
  • Having given informed consent
  • Healthy volunteers:
  • French-English or English-French bilinguals with at least a C1 level (CECR) in both languages
  • At least 12 years of schooling (French BAC)
  • Right-handed (Edinburgh test, 1971)
  • Early bilinguals: age of acquisition of both languages < 3 years
  • Late bilinguals: age of acquisition of the L2 > 10 years

Who cannot join

  • Patients:
  • Contra-indication for MRI
  • Left-handed or ambidexter (less than +80 at the Edinburgh test - 1971)
  • Mini-Mental State Examination <26
  • Patient who cannot respect the procedures, visits, exams described in the protocol
  • Any other medical or psychiatric affection which renders inclusion of the patient to the study inappropriate as judged by the principal investigator
Show all 10Show fewer
  • Healthy volunteers:
  • Contra-indication for MRI
  • Mini-Mental State Examination < 26
  • Age of acquisition of one of the language between 3 and 10 years

Trial locations and contacts

1 site in 1 country.

France1 site
  • University Hospital of Toulouse

    Toulouse, 31059

Other trials in France

About this study

Official title: Neural Correlates of Language Control in Bilinguals. Functional MRI and Stimulation Mapping Data in Awake Surgery. (NEUROSWITCH)

For bilingual and multilingual patients, brain activation and Electric Stimulation Mapping studies have shown that different languages may be localized, at least partially, in distinct microanatomical systems located within the same gross anatomical areas.

The present investigation involves both types of healthy bilinguals with carefully controlled proficiency levels, as well as bilingual patients suffering from low-grade glioma.

Functional magnetic resonance imaging data will be collected while the participants perform a picture naming task in blocked conditions for both languages (either English or French) or in switch condition (English and French). A stimulation mapping study will be conducted in the patients during awake surgery with the same tasks.

Conditions
Bilingualism
Being tested
functional magnetic resonance imaging
Keywords
bilinguals, language control, executive functions, functional MRI, stimulation mapping, brain tumors
Medical subject headings
Brain Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • functional magnetic resonance imagingDevice

    Stimuli will be presented in 3 language conditions, French, English and "switch" in which the participant alternates between English and French every trial. A block design will be used, with 7 line drawings per language condition. Four 9-minute runs will be performed, there being 2 action runs and 2 object runs. In each run, there are 6 blocks of each language condition, presented in a fixed random order. No drawings are repeated. Each stimulus is preceded either by an English or a French prompt word ("to" or "faire" for actions and, "say" or "dire" for objects) for 450 msec; stimuli are presented for 1.5 seconds and followed by a blank screen for 1 second. Language blocks are separated by a variable duration (from 8 to 10 seconds).

Study groups in NCT02391493
Study groupRoleWhat they receive
healthy early bilingualsExperimentalhealthy early bilinguals functional magnetic resonance imaging
Receives: Device: functional magnetic resonance imaging
healthy late bilingualsExperimentalhealthy late bilinguals functional magnetic resonance imaging
Receives: Device: functional magnetic resonance imaging
bilingual patientsExperimentalbilingual patients suffering from low-grade glioma in the language areas functional magnetic resonance imaging
Receives: Device: functional magnetic resonance imaging

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Brain activity

    The primary judgment criteria is brain activity as measured by functional magnetic resonance imaging :

    • In blocked vs. switched naming in control subjects
    • In switched naming in early vs. late bilingual subjects
    • In blocked vs. switched naming in early vs. late bilingual subjects

    Measured: 24 hours

Secondary outcomes (1)
  1. Brain activity

    The secondary judgment criteria is brain activity measured by functional magnetic resonance imaging :

    • In blocked vs. switched naming in the patients
    • In French vs. English and English vs. French naming in the late bilinguals
    • In French vs. English and English vs. French naming in the early bilinguals
    • In French vs. LX and LX vs. French naming in the patients.

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Mar 2015 (estimated)
  2. Study startNov 2014
  3. Primary completionDec 2017
  4. Study completionDec 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02391493
Sponsor's protocol ID
13 245 03
Other IDs
HAO 2013
Acronym
NEUROSWITCH
Status last verified
Mar 2018
First submitted
4 Mar 2015
Last updated
27 Mar 2018
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing functional magnetic resonance imaging in people with Bilingualism, run by University Hospital, Toulouse at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 15 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Mar 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Brain activity (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in